Virus-like particles induce mhc class i-restricted t-cell responses

Intervirology

Volumn 39, Issue 1-2, 1996, Pages 111-119

  Schirmbeck, Reinhold ^a   Böhm, Waltraud ^a   Reimann, Jörg ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

CD 8+ cytotoxic T lymphocytes; Hepatitis B virus small surface antigen; MHC class I restricted antigen presentation; Virus like particles as vaccines

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MONOMER; PLASMID DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ARTICLE; CYTOTOXIC T LYMPHOCYTE; HEPATITIS B VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; T LYMPHOCYTE; VACCINATION; VIRUS PARTICLE;

ANIMALS; ANTIGEN PRESENTATION; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MICE; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; VACCINES, SYNTHETIC; VIRION;

ANIMALIA; HEPATITIS B VIRUS; VACCINIA; VACCINIA VIRUS;

EID: 0029845430     PISSN: 03005526     EISSN: 14230100     Source Type: Journal    
DOI: 10.1159/000150482     Document Type: Article

References (82)

1. Doherty PC, Allan W, Eichelberger M, et al: Roles of a I and y8 T cell subsets in viral immunity, Annu Rev Immunol 1992:10:123-151.
2. Kaufmann SH: Immunity against intracellular bacteria: Biological effectors functions and antigen specificity of T lymphocytes, Curr Top Microbiol Immunol 1988:138:141-176.
3. Tarleton RL, Koller BH, Latour A, et al: Susceptibility of L-m icroglobul in-dcficient mice to Trypanosoma cruzi infection, Nature 1992: 356:338-340.
4. Aggarwal A, Kumar S, Jaffe R, et al: Oral salmonella: Malaria circumsporozoite recombinants induce specific C'D8+ cytotoxic T cells, J Exp Med 1990:172:1083-1090.
5. Brochier B, Kieny M-P, Costy F, et al: Large-scale eradication of rabies using recombinant vaccinia-rabics vaccine, Nature 1991:354:520-522.
6. Stover CK, de la Cruz VF, Fuerst TR, et al: New use of BCG for recombinant vaccine, Nature 1991;351:456-460.
7. Daniel MD, Kirchhoff F, Czajak SC, et al: Prtv tective effects of a live attenuated S1V vaccine with a deletion in the nef gene, Science 1992; 258:1938-1941.
8. Schafer R, Portnoy DA, Brassell SA, et al: Induction of a cellular immune response to a foreign antigen by a recombinant Listeria monocytogenes vaccine, J Immunol 1992; 149:53- 59.
9. Ulmer JB, Donnelly JJ, Parker SE, et al: Heterologous protection against influenza by injection of DNA encoding a viral protein, Science 1993;259:1745-1749.
10. Nabel GJ, Chang AE, Nabel EG, et al: Immunotherapy for cancer by direct gene transfer into tumors, Hum GeneTher 1994;5:57-77.
11. Ulmer JB, Deck RR, DcWitl CM, et al: Protective immunity by intramuscular injection of low doses of influenza virus DNA vaccines, Vaccine 1994;12:1541-1544.
12. Xiang ZQ, Spitalnik S, Tran M, et al: Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus, Virology 1994; 199:132-140.
13. Martins LP, Lau LL, Asano MS, el al: DNA vaccination against persistent viral infection, J Virol 1995:69:2574-2582.
14. Schirmbeck R, Böhm W, Ando K, ct al: Nucleic acid vaccination primes hepatitis B surface antigen-specific cytotoxic T lymphocytes in nonrespondcr mice, J Virol 1995:69:5929-5934.
15. Davis HL, Schirmbcck R, Reimann J, et al: DNA-mediatcd immunization in mice induces a potent MHC class I-restricted cytotoxic T lymphocyte response to the hepatitis B surface antigen, Human Gene Therapy 1995:6:1447- 1456.
16. Xiang ZQ, Ertl HCJ: Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines, Immunity 1995:2:129-135.
17. Yokoyama M, Zhang J, Whitton JL: DNA immunization confers protection against lethal lymphocytic choriomeningitis virus infection, J Virol 1995:69:2684-2688.
18. Takahashi H, Takeshita T, Morcin B, et al: Induction of CD8+ cytotoxic T cells by immunization with purified HIV-I envelope protein in ISCOMs, Nature 1990:344:873-875.
19. Hccg K, Kuon W, Wagner H: Vaccination of class 1 major histocompatibility complex (MHC)-restricted murine CD8+ cytotoxic T lymphocytes towards soluble antigens: immu-nostimulating-ovalbumin complexes enter the class I M LIC-restricted antigen pathway and allow sensitization against the immunodominant peptide, EurJ Immunol 1991:21:1523-1527.
20. van Binnendijk RS, Van Baalen CA, Poelen MCM, et al: Measles virus transmembrane fusion protein synthesized de novo or presented in immunostimulating complexes is endogenously processed for HLA class I- and class II-restricted cytotoxic T cell recognition, J Exp Med 1992:176:119-128.
21. Collins DS, Findlay K, Harding CV: Processing of exogenous liposome-encapsulated antigens in vivo generates class I MHC-restricted T cell responses, J Immunol 1992;148:3336- 3341.
22. Huang L, Reddy R, Nair SK, et al: Liposomal delivery of soluble protein antigens for class I MHC-mediated antigen presentation, Res Immunol 1992;143:192-196.
23. Lopes LM, Chain BM: Liposome-mediated delivery stimulates a class I-restricted cytotoxic T cell response to soluble antigen, EurJ Immunol 1992:22:287-290.
24. Nair S, Zhou X, Huang L, et al: Class I restricted CTL recognition of a soluble protein delivered by liposomes containing lipophilic polylvsines, J Immunol Methods 1992:152: 237-243.
25. Nair S, Zhou F, Reddy R, et al: Soluble proteins delivered to dendritic cells via pH-sensi-tive liposomes induce primary cytotoxic T lymphocyte responses in vitro, J Exp Med 1992; 175:609-612.
26. Reddy R, Zhou F, Nair S, et al: In vivo cytotoxic T lymphocyte induction with soluble proteins administered in liposomes, J Immunol 1992:148:1585-1589.
27. Zhou F, Rouse BT, Huang L: Induction of cytotoxic T lymphocytes in vivo with protein antigen entrapped in membranous vehicles, J Immunol 1992:149:1599-1604.
28. Nair S, Buiting AMJ, Rouse RJ, et al: Role of macrophages and dendritic cells in primary cytotoxic T lymphocyte responses, Int Immunol 1995;4:679-688.
29. Wu YJ, Gardner BH, Kushner NN, et al: Accessory' cell requirements for saponin adjuvant-induced class I MHC antigen-restricted cytotoxic T-lymphocytcs, Cell Immunol 1994:154: 393-406.
30. Wu JY, Gardner BH, Murphy CI, et al: Saponin adjuvant enhancement of antigen-specific immune responses to an experimental HIV-I vaccine, J Immunol 1992:148:1519-1525.
31. Newman MJ, Wu JY, Gardner BH, et al: Saponin adjuvant induction of ovalbumin-specific CD8+ cytotoxic T lymphocyte responses, J Immunol 1992:148:2357-2362.
32. Harris SJ, Gearing AJ, Layton GT, et al: Enhanced proliferative cellular responses to HI V-1 V3 peptide and gpl20 following immunization with V3:Ty virus-like particles, Immunology 1992:77:315-321.
33. Layton GT, Harris SJ, Gearing AJ et al: Induction of HIV-specific cytotoxic T lymphocytes in vivo with hybrid HIV-1 V3:Ty-virus-like particles, J Immunol 1993:151:1097-1107.
34. Griffiths JC, Harris SJ, Layton GT, et al: Hybrid human immunodeficiency virus Gag particles as an antigen carrier system: induction of cytotoxic T-cell and humoral responses by a Gag:V3 fusion, J Virol 1993:67:3191-3198.
35. Schirmbcck R, Demi L, Melber K, et al: Priming of class I-restricted cytotoxic T lymphocytes by vaccination with recombinant protein antigens, Vaccine 1995:13:857-865.
36. Schirmbcck R, Melber K, Mertcns T, et al: Antibody and cytotoxic T-cell responses to soluble hepatitis B virus (HBV)S antigen in mice: implication for the pathogenesis of HBV-in-duced hepatitis, J Virol 1994:68:1418-1425.
37. Schirmbcck R, Melber K, Kuhrobcr A, et al: Immunization with soluble hepatitis B virus surface (S) protein particles elicits murine H-2 class I-restricted CD8+ cytotoxic T lymphocyte responses in vivo, J Immunol 1994:152:1110-1119.
38. Schirmbcck R, Zerrahn J, Kuhrobcr A, et al: Immunization with soluble simian virus 40 large T antigen induces a specific response of CD3+ CD4- CD8+ cytotoxic T lymphocytes in mice, EurJ Immunol 1992:22:759-766.
39. Schirmbeck R, Dcppert W, Kury E, et al: In vitro expansion distorts the detectable pattern of specific recognition of in vivo primed cytotoxic T lymphocyte populations, Cell Immunol 1993:149:444-449.
40. Schirmbeck R, Zerrahn J, Kuhrobcr A, et al: Immunization of mice with the N-terminal (1-272) fragment of simian virus 40 large T-anti-gcn (without adjuvants) specifically primes cytotoxic T lymphocytes, Eur J Immunol 1993; 23:1528-1534.
41. Schirmbeck R, Melber K, Mertens T, et al: Selective stimulation of murine cytotoxic T cell and antibody responses by particulate or monomeric hepatitis B virus surface (S) antigen, EurJ Immunol 1994;24:1088-1096.
42. Schirmbeck R, Bohm W, Reimann J: Injection of detergent-denatured ovalbumin primes murine class I-rcstricted cytotoxic T cells in vivo, EurJ Immunol 1994:24:2068-2072.
43. Bachmann MF, Kiindig TM, Freer G, et al: Induction of protective cytotoxic T cells with viral proteins, EurJ Immunol 1994:24:2128- 2236.
44. Weidt G, Utcrmohlcn O, Zerrahn J, et al: CD8+ T lymphocyte-mediated antiviral immunity in mice as a result of injection of recombinant viral proteins, J Immunol 1994:153: 2554-2561.
45. Guagliardi LE, Koppelman B, Blum JS, et al: Co-localization of molecules involved in antigen processing and presentation in an early endocytic compartment, Nature 1990:343: 133-139.
46. Brodsky FM, Guagliardi LE: The cell biology of antigen processing and presentation, Annu Rev Immunol 1991;9:707-744.
47. Necfjcs JJ, Ploegh HL: Intracellular transport of MHC class 11 molecules, Immunol Today 1992:13:179-184.
48. Tulp A, Verwoerd D, Dobberstein B, et al: Isolation and characterization of the intracellular MHC class II compartment, Nature 1994:369: 120-126.
49. Townsend ARM, Bodmer HC: Antigen recognition by class I-restricted T lymphocytes, Annu Rev Immunol 1989;7:601-624.
50. Yewdcll JW, Bcnnink JR: Cell biology of antigen processing and presentation to major histocompatibility complex class I molecule-restricted T lymphocytes, Adv Immunol 1992: 52:1-123.
51. Germain RN, Margulies DH: The biochemistry and cell biology of antigen processing and presentation, Annu Rev Immunol 1993;11: 403-450.
52. Hccrman K-H, Gerlich WH: In McLachlan A (ed): Surface Proteins of Hepatitis B Virus, Boca Raton, CRC Press, 1991, pp 109.
53. Schirmbeck R, Bohnt W, Melber K, et al: Processing of exogenous heat-aggregated dcna-turedjor particulate (native) hepatitis B surface antigen for class I-restrictcd epitope presentation. Immunol 1995:155:4676-4684.
54. Bohm W, Schirmbeck R, Elbe A, et al: Exogenous hepatitis B surface antigen particles processed by dendritic cells or macrophages prime murine MHC class I-restricted cytotoxic T lymphocytes in vivo, J Immunol 1995:155: 3313-3321.
55. Schirmbeck R, Melber K, Reimann J: Hepatitis B virus surface particles are processed in a novel cndosomal pathway for MHC class I-rcstrictcd epitope presentation, Eur J Immunol 1995;25:1063-1070.
56. d molecules capture peptides from endocy-tosed, exogenous antigens for MHC class I-restricted presentation, Eur J Immunol 1996; submitted.
57. Pfeifer JD, Wick MJ, Roberts RL, et al: Phagocytic processing of bacterial antigens for class I MHC presentation to Tcells, Nature 1993:361: 359-362.
58. Pfeifer JD, Wick MJ, Harding CV, et al: Processing of defined T-cell epitopes after phagocytosis of intact bacteria by macrophages, Infect Agents Dis 1993;2:249-254.
59. Harding CV, Song R: Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules, J Immunol 1994:153:4925-4933.
60. Schirmbeck R, Reimann J: Targeting of exogenous protein antigens to a novel cndosomal processing pathway for class I-restricted presentation, Behring Inst Mitt 1994:95:14-22.
61. Wagner R, Demi L, Schirmbeck R, et al: Induction of a MHC class I-restricted, CD8+ cytolytic T cell response by chimeric H1V-I virus-like particles in vivo: Implications on HIV vaccine development, Behring Inst Mitt 1994:95:23- 34.
62. Doe B, Sleimer KS, Walker CM: Induction of HIV-1 envelope (gpl20)-specific cytotoxic T lymphocyte responses in mice by recombinant CHO cell-derived gpl20 is enhanced by enzymatic removal of N-linked glycans, Eur J Immunol 1994:24:2369-2376.
63. Deres K, Schild H, Wiesmiiller K-H, et al: In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine, Nature 1989:342:561-564.
64. Schild H, Norda M, Dercs K, et al: Fine specificity of cytotoxic T lymphocytes primed in vivo either with virus or synthetic lipopeptide vaccine or primed in vitro with peptide, J Exp Med 1991:174:1665-1668.
65. Schild H, Deres K, Wiesmiiller K-H, et al: Efficiency of peptides and lipopeptidcs for in vivo priming of virus-specific cytotoxic T cells, Eur J Immunol 1991:21:2649-2654.
66. Martinon F, Gras-Masse H, Bout llion C, et al: Immunization of mice with lipopcptides bypasses the prerequisite for adjuvant: Immune response of BALB/c mice to human immunodeficiency virus envelope glycoprotein, J Immunol 1992; 149:3416-3422.
67. Nardclli B, Tam JP: Cellular immune responses induced by in vivo priming with a lipid-conjugated multimeric antigen peptide, Immunology 1993;79:355-361.
68. lnaba K, Young JW, Steinman RM: Direct activation of CD8+ cytotoxic T lymphocytes by dendritic cells, J Exp Med 1987:166:182-194.
69. Boog CJP, Boes J, Melief CJM: Stimulation with dendritic cells decreases or obviates the CD4+ helper cell requirement in cytotoxic T lymphocyte responses, Eur J Immunol 1988: 18:219-223.
70. Kast WM, Boog CJP, Roep BO, et al: Failure or success in the restoration of virus-specific cytotoxic T lymphocyte response defects of dendritic cells, J Immunol 1988:140:3186-3193.
71. Macatonia SE, Taylor PM, Knighl SD, et al: Primary stimulation by dendritic cells induces anti-viral proliferative and cytotoxic T cell responses in vitro, J Exp Med 1989:169:1255- 1264.
72. Young JW, Steinman RM: Dendritic cells stimulate primary human cytolytic lymphocyte responses in the absence of CD4* helper T cells, J Exp Med 1990:171:1315-1332.
73. De Bruijn ML, Nieland JD, Schumacher TN, et al: Mechanisms of induction of primary virus-specific cytotoxic T lymphocyte responses, EurJ Immunol 1992;22:3013-3020.
74. Nonacs R, Humborg C, Tam JP, et al: Mechanisms of mouse spleen dendritic cell function in the generation of influenza-specific, cytolytic T lymphocytes, J Exp Med 1992:176:519-529.
75. Nair S, Babu JS, Dunham RG, et al: Induction of primary, antiviral cytotoxic, and proliferative responses with antigens administered via dendritic cells, J Virol 1993:67:4062-4069.
76. Bhardwaj N, Bender A, Gonzalez N, et al: Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8* T cells, J Clin Invest 1994; 94:797-807.
77. Elbe A, Schlcischitz S, Strunk D, et al: Fetal skin-derived MHC class I’, MHC class II-den-dritic cells stimualtc MHC class I-rcstricted responses of unprimcd CD8* T cells, J Immunol 1994:153:2878-2889.
78. Debrick JE, Campbell PA, Staerz UD: Macrophages as accessory cells for class I MHC-restrictcd immune responses, J Immunol 1991; 147:2846-2851.
79. Denkers EY, Gazzinelli RT, Hieny S, et al: Bone marrow macrophages process exogenous Toxoplasma gondii polypeptides for recognition by parasite-specific cytolytic T lymphocytes, J Immunol 1993:150:517-526.
80. Kovacsovics Bankowski M, Clark K, Benacer-raf B, et al: Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages, Proc Natl Acad Sei USA 1993;90:4942-4946.
81. Rock KL, Rothslcin L, Gamble S, et al: Characterization of antigen-presenting cells that present exogenous antigens in association with class I MHC molecules, J Imunol 1993; 150: 438-446.
82. Udono H, Levey DL, Srivastava PK: Cellular requirements for tumor-specific immunity elicited by heat shock proteins: Tumor rejection antigen gp96 primes CD8* T cells in vivo, Proc Nall Acad Sei USA 1994:91:3077-3081.